MBX MBX Biosciences, Inc.
Fundamentals / CIK 0001776111 / USDMBX Biosciences, Inc. reported $500.6M in total assets and a net loss of $145.1M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MBX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$160.3M Operating profit
-
Net Income FY 2025-$145.1M GAAP bottom line
-
Diluted EPS FY 2025-$2.99 Split-adjusted
-
Free Cash Flow FY 2025-$99.33M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$481.6M Total debt: $3.29M
Annual revenue and net income
3 fiscal years (2023 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | $79.16M | $57.41M | $28.53M |
| Total Operating Expenses | $98.06M | $68.19M | $35.31M |
| Operating Income | -$98.06M | -$68.19M | -$35.31M |
| EBITDA | -$97.81M | -$67.95M | -$35.15M |
| Income Before Tax | -$87.00M | -$61.90M | -- |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | -$87.00M | -$61.92M | -$32.56M |
| Basic EPS | -$2.38 | -$5.82 | -$31.96 |
| Diluted EPS | -$2.38 | -$5.82 | -$31.96 |
| Basic Shares Outstanding | 36.5M | 10.6M | 1.0M |
| Diluted Shares Outstanding | 36.5M | 10.6M | 1.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $32.05M | $30.98M | $18.47M | $19.76M | $19.27M | $17.72M | $22.41M | $15.22M |
| Total Operating Expenses | $66.34M | $40.93M | $27.27M | $25.80M | $23.93M | $21.80M | $26.53M | $18.61M |
| Operating Income | -$66.34M | -$40.93M | -$27.27M | -$25.80M | -$23.93M | -$21.80M | -$26.53M | -$18.61M |
| EBITDA | -$66.24M | -$40.83M | -$27.20M | -$25.73M | -$23.83M | -$21.70M | -$26.45M | -$18.55M |
| Net Income | -$62.42M | -$37.09M | -$23.52M | -$22.09M | -$21.62M | -$19.41M | -$23.88M | -$15.59M |
| Basic EPS | -$1.29 | -$0.78 | -$0.50 | -- | -$0.63 | -$0.58 | -$0.71 | -- |
| Diluted EPS | -$1.29 | -$0.78 | -$0.50 | -- | -$0.63 | -$0.58 | -$0.71 | -- |
| Basic Shares Outstanding | 48.6M | 47.7M | 46.6M | -- | 34.2M | 33.4M | 33.4M | -- |
| Diluted Shares Outstanding | 48.6M | 47.7M | 46.6M | -- | 34.2M | 33.4M | 33.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $75.29M | $49.35M | $30.52M |
| Short-Term Investments | $298.4M | $212.8M | $50.15M |
| Cash & Short-Term Investments | $373.7M | $262.1M | $80.68M |
| Other Current Assets | $861K | $803K | $133K |
| Total Current Assets | $381.5M | $267.3M | $83.47M |
| Property, Plant & Equipment, Net | $2.73M | $1.08M | $439K |
| Other Non-Current Assets | $383K | $50K | $50K |
| Total Non-Current Assets | $3.60M | $1.25M | $715K |
| Total Assets | $385.1M | $268.5M | $84.18M |
| Accounts Payable | $2.98M | $5.33M | $1.39M |
| Total Current Liabilities | $15.49M | $11.05M | $3.93M |
| Total Non-Current Liabilities | $426K | $42K | $365K |
| Total Liabilities | $15.92M | $11.09M | $4.29M |
| Total Debt (incl. Leases) | $596K | $171K | $324K |
| Common Stock | $6.0K | $5.0K | $1.0K |
| Retained Earnings | -$224.5M | -$137.5M | -$75.58M |
| Accumulated Other Comp. Income | $286K | $55K | $60K |
| Total Stockholders' Equity | $369.2M | $257.4M | -$72.47M |
| Total Equity | $369.2M | $257.4M | -$72.47M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $161.7M | $54.12M | $45.21M | $75.29M | $223.1M | $39.78M | $29.90M | $49.35M |
| Short-Term Investments | $319.9M | $364.5M | $394.8M | $298.4M | $168.5M | $185.1M | $210.9M | $212.8M |
| Cash & Short-Term Investments | $481.6M | $418.6M | $440.0M | $373.7M | $391.7M | $224.9M | $240.8M | $262.1M |
| Other Current Assets | $2.48M | $1.16M | $814K | $861K | $882K | $472K | $626K | $803K |
| Total Current Assets | $492.8M | $427.9M | $448.5M | $381.5M | $397.5M | $229.2M | $244.3M | $267.3M |
| Property, Plant & Equipment, Net | $5.00M | $4.66M | $3.13M | $2.73M | $2.00M | $1.73M | $1.51M | $1.08M |
| Other Non-Current Assets | $247K | $625K | $579K | $383K | $50K | $50K | $50K | $50K |
| Total Non-Current Assets | $7.86M | $8.05M | $4.17M | $3.60M | $2.57M | $2.33M | $1.65M | $1.25M |
| Total Assets | $500.6M | $435.9M | $452.7M | $385.1M | $400.1M | $231.5M | $245.9M | $268.5M |
| Accounts Payable | $6.80M | $4.36M | $6.97M | $2.98M | $3.77M | $5.76M | $4.25M | $5.33M |
| Total Current Liabilities | $25.17M | $23.66M | $14.57M | $15.49M | $12.06M | $11.76M | $10.48M | $11.05M |
| Total Non-Current Liabilities | $2.50M | $2.71M | $378K | $426K | $476K | $527K | $23K | $42K |
| Total Liabilities | $27.67M | $26.37M | $14.95M | $15.92M | $12.54M | $12.28M | $10.50M | $11.09M |
| Total Debt (incl. Leases) | $3.29M | $3.34M | $555K | $596K | $623K | $650K | $130K | $171K |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$347.5M | -$285.1M | -$248.0M | -$224.5M | -$202.4M | -$180.8M | -$161.4M | -$137.5M |
| Accumulated Other Comp. Income | -$1.96M | -$1.22M | -$606K | $286K | $154K | $11K | $53K | $55K |
| Total Stockholders' Equity | $472.9M | $409.5M | $437.8M | $369.2M | $387.5M | $219.2M | $235.4M | $257.4M |
| Total Equity | $472.9M | $409.5M | $437.8M | $369.2M | $387.5M | $219.2M | $235.4M | $257.4M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | -$86.97M | -$61.92M | -$32.56M |
| Depreciation & Amortization | $248K | $244K | $157K |
| Stock-Based Compensation | $8.68M | $5.22M | $2.04M |
| Change in Payables | -$2.46M | $3.93M | $412K |
| Operating Cash Flow | -$79.95M | -$54.68M | -$31.98M |
| Capital Expenditure | -$1.93M | -$874K | -$129K |
| Free Cash Flow | -$81.88M | -$55.55M | -$32.11M |
| Purchases of Investments | -$358.1M | -$239.5M | -$63.80M |
| Investing Cash Flow | -$83.70M | -$160.6M | -$30.93M |
| Common Stock Issued | $601.7M | -- | -- |
| Financing Cash Flow | $189.6M | $234.1M | $69.22M |
| Net Change in Cash | $25.94M | $18.83M | $6.31M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$62.42M | -$37.09M | -$23.52M | -$22.06M | -$21.62M | -$19.41M | -$23.88M | -$15.59M |
| Depreciation & Amortization | $100K | $100K | $64K | $60K | $100K | $100K | $77K | $58K |
| Stock-Based Compensation | $27.55M | $6.06M | $5.48M | $2.66M | $2.25M | $1.94M | $1.84M | $1.49M |
| Change in Payables | $3.17M | -$3.23M | $3.97M | -$861K | -$2.04M | $2.01M | -$1.56M | $645K |
| Operating Cash Flow | -$34.88M | -$22.62M | -$20.21M | -$18.30M | -$21.54M | -$17.43M | -$22.68M | -$16.04M |
| Capital Expenditure | -$1.19M | -$901K | -$437K | -$793K | -$399K | -$707K | -$30K | -$92K |
| Free Cash Flow | -$36.07M | -$23.52M | -$20.64M | -$19.09M | -$21.93M | -$18.14M | -$22.71M | -$16.13M |
| Purchases of Investments | -$29.73M | -$53.89M | -$154.2M | -$205.4M | -$46.40M | -$47.43M | -$58.89M | -$87.50M |
| Investing Cash Flow | $42.83M | $29.21M | -$97.10M | -$130.0M | $17.06M | $25.99M | $3.23M | -$67.34M |
| Common Stock Issued | -- | $0 | $688.8M | -- | -- | -- | -- | -- |
| Financing Cash Flow | $99.61M | $2.32M | $87.44M | $438K | $187.8M | $1.33M | $4.0K | -$132K |
| Net Change in Cash | $107.6M | $8.91M | -$29.87M | -$147.8M | $183.3M | $9.88M | -$19.45M | -$83.51M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Equity (ROE) | -23.6% | -24.1% | -- |
| Return on Assets (ROA) | -22.6% | -23.1% | -38.7% |
| Current Ratio | 24.62x | 24.19x | 21.26x |
| Quick Ratio | 24.12x | 23.72x | 20.55x |
| Debt to Equity | 0.00x | 0.00x | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -30.7% | -25.5% | -19.8% | -23.6% | -20.8% | -35.1% | -31.2% | -24.1% |
| Return on Assets (ROA) | -29.0% | -23.9% | -19.1% | -22.6% | -20.1% | -33.3% | -29.9% | -23.1% |
| Current Ratio | 19.58x | 18.08x | 30.79x | 24.62x | 32.95x | 19.50x | 23.31x | 24.19x |
| Quick Ratio | 19.14x | 17.69x | 30.21x | 24.12x | 32.47x | 19.13x | 22.97x | 23.72x |
| Debt to Equity | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |